About Biorasi
Biorasi is a Healthcare company based in Miami (United States) founded in 2002, and was acquired by RLH in November 2018. Full-service CRO operations are conducted globally with proprietary trial software. The company has 104 employees. Its Indian entity Biorasi Clinical Services Private Limited reported revenue of ₹15.16 Cr. Biorasi offers products and services including Phase Ib-III Trials, Patient Engagement and Recruitment, and Decentralized and Virtual Solutions. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its competitors include Celgene, Medelis WCCT Global and Syneos Health; 2 of its 3 listed competitors have raised funding.
Company details
The company was founded in 2002 and is headquartered in Miami, United States, with global operations in the clinical research sector. Full-service contract research organization (CRO) capabilities are offered, including management of biosimilar trials and study rescue services. Expertise covers therapeutic areas such as nephrology, neurology, womens health, autoimmune diseases, immunology, and oncology. A proprietary platform named TALOS is utilized for trial optimization and proactive issue identification.
- Headquarters Miami, United States
- Employees 104
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website biorasi.com
- Social LinkedIn X Facebook Instagram
- Acquired by RLH (Nov 2018)
- Legal Name Biorasi Clinical Services Private Limited
- Date of Incorporation 22 Jul, 2022
- Indian entity revenue₹15.16 Cr
FY 2024 · +383% YoY
- Indian entity net profit₹86.8 Lakh
FY 2024 · 6% margin
- Indian entity EBITDA₹1.43 Cr
FY 2024 · 9% margin
- Investors
- Employee Count104
- Acquired byRLH
(Nov 2018)
Associated legal entities of Biorasi
Biorasi operates through Biorasi Clinical Services Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Biorasi Clinical Services Private Limited CIN U74999MH2022FTC387344 | Active | 22 Jul 2022 | Thane, Maharashtra | ₹15.2 Cr | 63 | 2 | View details |
Products & Services of Biorasi
Biorasi offers a comprehensive portfolio of products and services, including Phase Ib-III Trials, Patient Engagement and Recruitment, and Decentralized and Virtual Solutions.
Conducts phases of clinical trials for drug and device testing.
Optimizes strategies for faster patient enrollment in trials.
Enables remote monitoring and virtual conduct of clinical studies.
Investors in Biorasi
Biorasi has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include RLH Equity Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are made in tech-enabled service firms. | rlhequity.com | Los Angeles, United States |
Investor details for Biorasi
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Biorasi Clinical Services Private Limited (Biorasi)
Biorasi Clinical Services Private Limited is the primary company behind Biorasi. The board of Biorasi Clinical Services Private Limited currently have 2 directors; the longest-serving is Sagar Prabhakar Patil, appointed in 2022.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sagar Prabhakar Patil DIN 07822491 | Director | 22 Jul 2022 | 4 yrs 3 mo | Biorasi Clinical Services Private Limited |
| Christopher Paul Obrien DIN 09682828 | Director | 22 Jul 2022 | 4 yrs 3 mo | Biorasi Clinical Services Private Limited |
People of Biorasi
49 people are tracked at Biorasi (20 in leadership, 4 in board & advisors, 25 in team); the tracked headcount is 104.
| Name | Role | Group |
|---|---|---|
Chris O’Brien | CEO | Leadership |
Robert Royall | Director, Business Development | Leadership |
| Vice President, Asia Regional Operations | Leadership | |
Kristen Reis | Chief of Staff | Leadership |
Evgeny Poltanov | Director, Eastern European Operations | Leadership |
Mike Vitek | CFO | Leadership |
Dipali Patel | VP, Medical & Scientific Affairs | Leadership |
Paige Queen | VP, Clinical Operations | Leadership |
Karen Keeley | Director Of Business Development | Leadership |
Jane Fitchet | Director Of Business Development | Leadership |
Annabelle Harfouche Chartouni | Senior Director - Clinical Operations Europe | Leadership |
Amira Sabbagh | Associate Director Of Clinical Operations | Leadership |
Rim Ibrahim Bitar | Senior Director Project Management | Leadership |
Olga Frunze | Head Of Russian Operations & The Regional BD Director | Leadership |
Marvin Yip | Vice President, Controller | Leadership |
Bruce Hall | Director Business Development | Leadership |
Atik Khan | Director, Clinical Data Management | Leadership |
Cara Jacobs | Vice President, Legal | Leadership |
Raul E. Lopez | Director, Clinical Systems, Data Management | Leadership |
Sara Vaidya | VP, Data Sciences & Biometrics | Leadership |
29 more people are available in the full profile.
Complete people profiles for Biorasi
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Biorasi
Figures of Biorasi Clinical Services Private Limited, the primary company behind Biorasi, for FY 2024. Revenue was ₹15.16 Cr (+383% year on year). Net profit was ₹86.8 Lakh (6% margin). EBITDA was ₹1.43 Cr (9% margin).
- ₹15.16 CrRevenue · FY 2024 · +383% YoY
- ₹86.8 LakhNet profit · 6% margin
- ₹1.43 CrEBITDA · 9% margin
- ₹1 LakhPaid-up capital
- 63Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Biorasi Clinical Services Private Limited are on its company page.
Detailed financial statements for Biorasi
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Biorasi
2 dated milestones of Biorasi across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Biorasi is founded.
- Exit Acquired by RLH.
Competitors of Biorasi
Biorasi has 3 listed competitors in our database, 2 of them funded. They include Celgene, Medelis WCCT Global and Syneos Health.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| celgene.com | 1986 | Summit, United States | $45M | 4,891 | Therapies for cancer and inflammatory diseases are developed. | |
| wcct.com | 1998 | Cypress, United States | $17M | 229 | Full-service CRO expertise in influenza and oncology research is offered. | |
| syneoshealth.com | 1984 | Raleigh, United States | 29,395 | CRO clinical development services are provided by Syneos Health. |
Detailed competitors of Biorasi
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Biorasi
The website of Biorasi (biorasi.com) receives about 2.5K visits a month and ranks #4,000,827 among all websites worldwide, #5,034 in Biotechnology and Pharmaceuticals.
- Monthly visits2.5K
▼ 24.7% vs previous month
- Unique visitors1.5K
per month
- Global rank#4,000,827
among all websites
- Category rank#5,034
Health · Biotechnology and Pharmaceuticals
- Bounce rate30%
- Pages per visit3.1
- Average visit1 min 54 sec
- DevicesDesktop 20% · Mobile 80%
Websites whose visitors overlap most with Biorasi. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
bioflorida.com | bioflorida.com | 100% | #3,210,845 | – | |
regsource.com | regsource.com | 94% | – | ||
danteresources.com | danteresources.com | 93% | – | ||
| ncgs.com | 92% | View details | |||
brainstimulation.columbia.edu | brainstimulation.columbia.edu | 57% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Biorasi
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Biorasi (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biorasi
Complete news archive for Biorasi
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biorasi
Biorasi was founded in 2002.
Biorasi is headquartered in Miami, United States. It is registered at Miami, Florida, United States.
Biorasi has 104 employees.
The primary company behind Biorasi, Biorasi Clinical Services Private Limited, reported revenue of ₹15.16 Cr for FY 2024, up 383% year on year.
The company was founded in 2002 and is headquartered in Miami, United States, with global operations in the clinical research sector. Full-service contract research organization (CRO) capabilities are offered, including management of biosimilar trials and study rescue services. Expertise covers therapeutic areas such as nephrology, neurology, womens health, autoimmune diseases, immunology, and oncology. A proprietary platform named TALOS is utilized for trial optimization and proactive issue identification.
Biorasi's top competitors include Syneos Health, Medelis WCCT Global and Celgene.
Biorasi offers Phase Ib-III Trials, Patient Engagement and Recruitment, and Decentralized and Virtual Solutions.
Biorasi has 1 investor. Key investors include RLH Equity Partners.
Biorasi operates through Biorasi Clinical Services Private Limited.
Yes. Biorasi was acquired by RLH in November 2018.
The legal entities of Biorasi currently have 2 directors, including Sagar Prabhakar Patil, Christopher Paul Obrien.